Cresco Labs Statistics
Total Valuation
Cresco Labs has a market cap or net worth of 200.80 million. The enterprise value is 622.43 million.
| Market Cap | 200.80M |
| Enterprise Value | 622.43M |
Important Dates
The last earnings date was Friday, March 14, 2025.
| Earnings Date | Mar 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +6.69% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 329.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.06, with an EV/FCF ratio of 5.51.
| EV / Earnings | -8.36 |
| EV / Sales | 0.86 |
| EV / EBITDA | 3.06 |
| EV / EBIT | 5.48 |
| EV / FCF | 5.51 |
Financial Position
The company has a current ratio of 3.12, with a Debt / Equity ratio of 1.65.
| Current Ratio | 3.12 |
| Quick Ratio | 2.00 |
| Debt / Equity | 1.65 |
| Debt / EBITDA | 3.20 |
| Debt / FCF | 5.66 |
| Interest Coverage | 1.90 |
Financial Efficiency
Return on equity (ROE) is -14.82% and return on invested capital (ROIC) is 6.54%.
| Return on Equity (ROE) | -14.82% |
| Return on Assets (ROA) | 5.16% |
| Return on Invested Capital (ROIC) | 6.54% |
| Return on Capital Employed (ROCE) | 8.88% |
| Revenue Per Employee | 246,813 |
| Profits Per Employee | -25,668 |
| Employee Count | 2,900 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 3.77 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -74.11% in the last 52 weeks. The beta is 2.04, so Cresco Labs's price volatility has been higher than the market average.
| Beta (5Y) | 2.04 |
| 52-Week Price Change | -74.11% |
| 50-Day Moving Average | 0.80 |
| 200-Day Moving Average | 1.27 |
| Relative Strength Index (RSI) | 32.95 |
| Average Volume (20 Days) | 931,550 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cresco Labs had revenue of 715.76 million and -74.44 million in losses. Loss per share was -0.22.
| Revenue | 715.76M |
| Gross Profit | 355.87M |
| Operating Income | 111.95M |
| Pretax Income | -10.62M |
| Net Income | -74.44M |
| EBITDA | 171.05M |
| EBIT | 111.95M |
| Loss Per Share | -0.22 |
Balance Sheet
The company has 137.56 million in cash and 639.64 million in debt, giving a net cash position of -502.08 million.
| Cash & Cash Equivalents | 137.56M |
| Total Debt | 639.64M |
| Net Cash | -502.08M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 388.18M |
| Book Value Per Share | 1.36 |
| Working Capital | 199.92M |
Cash Flow
In the last 12 months, operating cash flow was 132.48 million and capital expenditures -19.49 million, giving a free cash flow of 112.99 million.
| Operating Cash Flow | 132.48M |
| Capital Expenditures | -19.49M |
| Free Cash Flow | 112.99M |
| FCF Per Share | n/a |
Margins
Gross margin is 49.72%, with operating and profit margins of 15.64% and -10.40%.
| Gross Margin | 49.72% |
| Operating Margin | 15.64% |
| Pretax Margin | -1.48% |
| Profit Margin | -10.40% |
| EBITDA Margin | 23.90% |
| EBIT Margin | 15.64% |
| FCF Margin | 15.79% |
Dividends & Yields
Cresco Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.69% |
| Shareholder Yield | -6.69% |
| Earnings Yield | -37.07% |
| FCF Yield | 56.27% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cresco Labs has an Altman Z-Score of -0.05. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.05 |
| Piotroski F-Score | n/a |